This is due to expression levels of PKCε being elevated in fatty liver, and inhibition of PKCε expression under conditions of fatty liver ameliorating the phenotype of insulin resistance (Samuel et al., 2010). This evidence concerns the gene PRKCE and Hepatic steatosis.